Cargando…
The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
BACKGROUND: MicroRNAs have emerged as critical modulators of carcinogenesis and tumor progression including renal cell carcinoma (RCC). MiR-622 plays as a tumor inhibitor in some types of cancer, however, its role in kidney cancer is unknown. The purpose of the present work is to investigate the fun...
Autores principales: | Li, Tian, Sun, Xiangzhou, Xu, Kewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833031/ https://www.ncbi.nlm.nih.gov/pubmed/29507713 http://dx.doi.org/10.1186/s13578-018-0212-8 |
Ejemplares similares
-
Retraction Note: The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway
por: Li, Tian, et al.
Publicado: (2023) -
Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer
por: Liu, Chuanyang, et al.
Publicado: (2019) -
miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma
por: Wang, Renjie, et al.
Publicado: (2018) -
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis
por: Lin, Xiaorong, et al.
Publicado: (2015) -
miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]
Publicado: (2021)